THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Robert Cichewicz to Candida albicans

This is a "connection" page, showing publications Robert Cichewicz has written about Candida albicans.
Connection Strength

2.663
  1. Resolving a Natural Product Cold Case: Elucidation of Fusapyrone Structure and Absolute Configuration and Demonstration of Their Fungal Biofilm Disrupting Properties. J Org Chem. 2023 Jul 07; 88(13):9167-9186.
    View in: PubMed
    Score: 0.833
  2. Polyketide glycosides from Bionectria ochroleuca inhibit Candida albicans biofilm formation. J Nat Prod. 2014 Oct 24; 77(10):2273-9.
    View in: PubMed
    Score: 0.456
  3. Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates. ACS Chem Biol. 2013 Apr 19; 8(4):840-8.
    View in: PubMed
    Score: 0.406
  4. Waikialoid A suppresses hyphal morphogenesis and inhibits biofilm development in pathogenic Candida albicans. J Nat Prod. 2012 Apr 27; 75(4):707-15.
    View in: PubMed
    Score: 0.381
  5. Fungal biofilm inhibitors from a human oral microbiome-derived bacterium. Org Biomol Chem. 2012 Mar 14; 10(10):2044-50.
    View in: PubMed
    Score: 0.378
  6. Persephacin Is a Broad-Spectrum Antifungal Aureobasidin Metabolite That Overcomes Intrinsic Resistance in Aspergillus fumigatus. J Nat Prod. 2023 08 25; 86(8):1980-1993.
    View in: PubMed
    Score: 0.210
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES